China Approves Galderma’s Relfydess for Frown Lines
China’s NMPA approved Relfydess for temporary improvement of moderate-to-severe frown lines in adults.
Related stories
US transportation sec. Duffy: flight operations gradually returning to normal this morning
L impact | REGULATION | Nov 14, 2026, 01:51 PM UTC
Italy Fines Meta €805 Million Over Android Users’ Data Access
Italy’s data protection agency said Meta accessed Android users’ photos and videos without consent or notification.
M impact | REGULATION | Nov 14, 2026, 01:04 PM UTC
Italy Fines Meta $887 Million Over Android Users' Data Access
Italy fined Meta over Android users' data access. The wire headline reports a fine of $887 million.
M impact | REGULATION | Nov 14, 2026, 01:04 PM UTC
Italy Fines Meta €805 Million Over Android User Data
Italy’s data protection agency said it fined Meta Platforms €805 million ($887 million) for allegedly accessing Android users’ photos and videos without consent or informing them.
M impact | REGULATION | Nov 14, 2026, 12:27 PM UTC
Italy fines Meta $887 million over Android data access
Italy fined Meta $887 million over access to Android users’ data, Reuters reported.
M impact | REGULATION | Nov 14, 2026, 12:27 PM UTC
Italy Fines Meta €805 Million Over Alleged Data Use Without Consent
Italy’s data protection agency fined Meta over the alleged use of Android users’ videos and photos without consent.
M impact | REGULATION | Nov 14, 2026, 12:18 PM UTC